Crossmark

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials

Crossref DOI link: https://doi.org/10.1007/s11764-024-01694-0

Published Online: 2024-10-18

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Juul, Sidsel J.

Rossetti, Sára

Aleman, Berthe M. P.

van Leeuwen, Flora E.

van der Kaaij, Marleen A. E.

Giusti, Francesco

Meijnders, Paul

Raemaekers, John M. M.

Kluin-Nelemans, Hanneke C.

Spina, Michele

Krzisch, Daphne

Bigenwald, Camille

Stamatoullas, Aspasia

André, Marc

Plattel, Wouter J.

Hutchings, Martin

Maraldo, Maja V.
Funding

Funding for this research was provided by:

National Hospital
License Information

Text and Data Mining valid from 2024-10-18

Version of Record valid from 2024-10-18
More Information

Article History

Received: 26 June 2024

Accepted: 9 October 2024

First Online: 18 October 2024

Declarations

:

: Not applicable (this study is exclusively register-based and all data are anonymized).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below